CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: The information gained from this research has important clinical implications for patients with CML as well as other cancer types associated with elevated CRKL expression and decreased miR‐429 expression, and may also have clinical impact on other diseases with dysregulated expression of CRKL and miR‐429.